ArticleAnnals of hematology2025

Efficacy and safety of isatuximab monotherapy to treat relapsed or refractory multiple myeloma: a pooled analysis of clinical trials.

Meletios Dimopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.